Kelly Deck

Insider Reports History

Location
C/O Inhibrx, Inc., 11099 N. Torrey Pines Road, Suite 280, La Jolla, CA
Signature
/s/ Kelly Deck
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kelly Deck:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Inhibrx, Inc. Chief Financial Officer Stock Option (right to buy) 0 $0 $34.12 May 30, 2024 Direct
Inhibrx Biosciences, Inc. Chief Financial Officer Stock Option (right to buy) 15K Apr 1, 2025 Direct

Insider Reports Filed by Kelly Deck

Symbol Company Period Transactions Value $ Form Type Date Filed Role
INBX Inhibrx Biosciences, Inc. Apr 1, 2025 1 $0 4 Apr 2, 2025 Chief Financial Officer
INBX Inhibrx, Inc. May 30, 2024 3 $0 4 May 30, 2024 Chief Financial Officer
INXB Inhibrx Biosciences, Inc. May 30, 2024 1 $0 4 May 30, 2024 Chief Financial Officer
INXB Inhibrx Biosciences, Inc. May 24, 2024 0 $0 3 May 24, 2024 Chief Financial Officer
INBX Inhibrx, Inc. May 6, 2024 2 -$675K 4 May 8, 2024 Chief Financial Officer
INBX Inhibrx, Inc. Mar 26, 2024 4 -$103K 4 Mar 28, 2024 Chief Financial Officer
INBX Inhibrx, Inc. Mar 20, 2024 3 -$701K 4 Mar 22, 2024 Chief Financial Officer
INBX Inhibrx, Inc. Mar 13, 2024 1 -$1.15M 4 Mar 15, 2024 Chief Financial Officer
INBX Inhibrx, Inc. Mar 8, 2024 1 -$1.52M 4 Mar 12, 2024 Chief Financial Officer
INBX Inhibrx, Inc. Mar 4, 2024 3 -$2.57M 4 Mar 6, 2024 Chief Financial Officer
INBX Inhibrx, Inc. Jan 3, 2023 1 $0 4 Jan 3, 2023 Chief Financial Officer
INBX Inhibrx, Inc. Jan 11, 2022 1 $0 4 Jan 25, 2022 Chief Financial Officer